Verrica director granted 16,000 stock options
Verrica Pharmaceuticals Inc. director Diem Nguyen received a grant of stock options covering 16,000 shares of common stock.
Rhea-AI Filing Summary
Verrica Pharmaceuticals Inc. director Diem Nguyen received a grant of stock options covering 16,000 shares of common stock. The options have an exercise price of $6.04 per share and expire on June 4, 2036.
These options were granted as compensation and vest in 12 equal monthly installments beginning on July 5, 2026. They will in any event be fully vested on the date of the next annual meeting of stockholders, subject to Nguyen’s continued service as a director through each vesting date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 16,000 shares
Grant/Award
1 txn
Insider
Nguyen Diem
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 16,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 16,000 contracts (Direct)
Footnotes (1)
- F1. The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 5, 2026 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director through the applicable vesting date.
Key Figures
Options granted: 16,000 options
Exercise price: $6.04 per share
Expiration date: June 4, 2036
+3 more
6 metrics
Options granted
16,000 options
Stock option grant to director Diem Nguyen
Exercise price
$6.04 per share
Strike price for the 16,000 stock options
Expiration date
June 4, 2036
Option term end for granted options
Underlying shares
16,000 shares
Common stock underlying the options
Vesting start
July 5, 2026
First monthly vesting date for options
Vesting pattern
12 equal monthly installments
Schedule for option vesting
Key Terms
Stock Option (right to buy), exercise price, vesting, expiration date, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
exercise price financial
"conversion_or_exercise_price: "6.0400""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares underlying this option shall vest and become exercisable in 12 equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: "2036-06-04T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Verrica Pharmaceuticals (VRCA) director Diem Nguyen report in this Form 4?
Diem Nguyen reported receiving a grant of stock options for 16,000 shares of Verrica Pharmaceuticals common stock. The grant is a compensation award, not an open-market purchase, and reflects additional incentive-based exposure to the company’s equity over time.
What are the key terms of Diem Nguyen’s Verrica Pharmaceuticals (VRCA) stock options?
The reported stock options cover 16,000 shares with an exercise price of $6.04 per share and an expiration date of June 4, 2036. These terms define the cost to exercise the options and the last date they can be used.
How do the Verrica Pharmaceuticals (VRCA) options granted to Diem Nguyen vest?
The options vest in 12 equal monthly installments starting July 5, 2026, and will be fully vested by the next annual meeting of stockholders. Vesting is conditioned on Nguyen’s continued service as a director through each applicable vesting date.
Is Diem Nguyen’s Verrica Pharmaceuticals (VRCA) Form 4 transaction a market buy or sell?
The Form 4 shows a grant or award acquisition of stock options, coded as an “A” transaction. It is a compensation-related award, not an open-market purchase or sale of Verrica Pharmaceuticals common stock in the public market.
How many Verrica Pharmaceuticals (VRCA) derivative securities does Diem Nguyen hold after this grant?
After the reported transaction, Nguyen holds 16,000 stock options related to Verrica Pharmaceuticals common stock. These options represent the right to buy 16,000 shares at $6.04 per share, subject to the vesting schedule and the June 4, 2036 expiration date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
